Filter News
Area of Research
- (-) Biology and Environment (30)
- (-) Supercomputing (17)
- Biological Systems (1)
- Clean Energy (24)
- Computational Biology (1)
- Electricity and Smart Grid (1)
- Fusion and Fission (18)
- Fusion Energy (4)
- Isotopes (6)
- Materials (30)
- Materials for Computing (1)
- National Security (7)
- Neutron Science (9)
- Nuclear Science and Technology (16)
- Quantum information Science (2)
News Topics
- (-) Biomedical (15)
- (-) Biotechnology (7)
- (-) Clean Water (8)
- (-) Grid (1)
- (-) Microscopy (8)
- (-) Nuclear Energy (2)
- (-) Physics (4)
- (-) Space Exploration (1)
- 3-D Printing/Advanced Manufacturing (2)
- Artificial Intelligence (23)
- Big Data (17)
- Bioenergy (26)
- Biology (43)
- Buildings (2)
- Chemical Sciences (4)
- Climate Change (30)
- Composites (1)
- Computer Science (50)
- Coronavirus (10)
- Cybersecurity (2)
- Decarbonization (16)
- Energy Storage (2)
- Environment (63)
- Exascale Computing (14)
- Frontier (13)
- High-Performance Computing (27)
- Hydropower (5)
- Machine Learning (9)
- Materials (5)
- Materials Science (10)
- Mathematics (3)
- Mercury (6)
- Nanotechnology (7)
- National Security (4)
- Net Zero (2)
- Neutron Science (6)
- Polymers (1)
- Quantum Computing (10)
- Quantum Science (10)
- Renewable Energy (1)
- Security (1)
- Simulation (15)
- Software (1)
- Summit (23)
- Sustainable Energy (17)
- Transportation (3)
Media Contacts
Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
Since the 1930s, scientists have been using particle accelerators to gain insights into the structure of matter and the laws of physics that govern our world.
From soda bottles to car bumpers to piping, electronics, and packaging, plastics have become a ubiquitous part of our lives.
A multi-institutional team, led by a group of investigators at Oak Ridge National Laboratory, has been studying various SARS-CoV-2 protein targets, including the virus’s main protease. The feat has earned the team a finalist nomination for the Association of Computing Machinery, or ACM, Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research.
NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.
New capabilities and equipment recently installed at the Department of Energy’s Oak Ridge National Laboratory are bringing a creek right into the lab to advance understanding of mercury pollution and accelerate solutions.
ORNL researchers have developed an intelligent power electronic inverter platform that can connect locally sited energy resources such as solar panels, energy storage and electric vehicles and smoothly interact with the utility power grid.
With the rise of the global pandemic, Omar Demerdash, a Liane B. Russell Distinguished Staff Fellow at ORNL since 2018, has become laser-focused on potential avenues to COVID-19 therapies.
In the race to identify solutions to the COVID-19 pandemic, researchers at the Department of Energy’s Oak Ridge National Laboratory are joining the fight by applying expertise in computational science, advanced manufacturing, data science and neutron science.